FW: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A
by Kareem Elsayad Feb. 26, 2025
by Kareem Elsayad Feb. 26, 2025
Feb. 26, 2025
Hi All,
Just quick update I got & wanted to share đ
Should be able to deal with this without your help -- only formatting stuff (but will contact you individually if/as needed).
Will keep you posted, and I guess you will get some form of confirmation when uploaded again.
Thanks again for being part of this & see you latest (hopefully) in Boston!
All the best,
Kareem
From: <giampaolo.pitruzzello(a)nature.com>
Reply to: <giampaolo.pitruzzello(a)nature.com>
Date: Wednesday, 26. February 2025 at 03:30
To: <kareem.elsayad(a)meduniwien.ac.at>
Subject: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A
25th February 2025
* Please ensure you delete the link to your author homepage in this e-mail if you wish to forward it to your co-authors.
Dear Kareem,
I have some good news. Your revised Consensus Statement article entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" has now been seen by the original referees #1 and #2, and their comments are included below. In light of their advice, I am delighted to say that we can now in principle offer to publish it, provided that you revise the paper to format it in accordance with our needs described below.
Our format requirements are explained in full at www.nature.com/nphoton/authors/index.html.
1. Title.
To avoid unwieldy titles, we ask that you use no more than 15 words, and no punctuation.
I believe that the current title is sufficiently clear and concise and that no further changes are needed.
2. Headings.
I think that the current headings are suitable and suggest no changes are made.
3. Abstract.
The abstract should serve as a general introduction to the topic, underlining the importance and relevance of a particular area, and as a brief guide to the coverage of the Consensus Statement article. Because we hope that scientists in a wide range of research areas will be interested in our articles, the abstract should be as accessible as possible, explaining essential but specialised terms concisely. We encourage you to show your abstract to colleagues in other fields to uncover any problematic concepts.
This paragraph must contain no more than 120 words and should not include references.
I suggest the version below which has been edited for reasons of length and clarity:
Brillouin Light Scattering (BLS) spectroscopy is a non-invasive, non-contact, label-free optical technique that can provide information on the mechanical properties of a material on the sub-micron scale. Over the last decade, BLS has seen increased applications in the life sciences, driven by the observed significance of mechanical properties in biological processes, the realization of more sensitive BLS spectrometers and the extension of BLS to an imaging modality. As with other spectroscopic techniques, BLS measurements not only detect signals characteristic of the investigated sample, but also of the experimental apparatus, and can be significantly affected by measurement conditions. Here, we report a consensus between researchers in the field. We aim to improve the comparability of BLS studies by providing reporting recommendations for the measured parameters and detailing common artifacts. Given that most BLS studies of biological matter are still at proof-of-concept stages and use different, often self-built, spectrometers, a consensus statement is particularly timely to ensure unified advancement.
4. Main text.
Please take care to ensure that the length does not exceed 6000 words
To ensure that a Consensus Statement article is likely to be accessible to as many readers as possible, it may be useful to ask a colleague from another discipline to read the manuscript before resubmitting it.
** Please ensure that all acronyms and symbols in equations are defined when first introduced.
** Please use UK English throughout.
** Please use a plain black font with no high highlighting or underlining.
** Please remove all figures from the main text and supply them as separate files.
5. Figures.
A Consensus Statement typically contains 4-6 display items (figures, tables and boxes) and these should be supplied separately from the main text.
*** Please ensure that all figures have scale bars as appropriate.
*** Please ensure that all axes of graphs are labelled clearly and supplied with units.
If your figures contain several parts, the parts should be labelled lower case a, b, and so on, and form a neat rectangle when assembled. For detailed instructions, please see our Guide for Authors at https://www.nature.com/documents/NRJs-guide-to-preparing-final-artwork.pdf
If you have reproduced or adapted figure from other venues, please provide us full details of the figures so that we can approach the relevant authors for high-resolution files and the relevant publishers for figure permissions. The form can be found here:
http://www.nature.com/documents/thirdpartyrights-table.doc
If the figures come from your group, please provide us their high-resolution files. Below are some of the guidelines. For more details, please refer to the digital figure guidelines at the end of this email.
Figure files must be supplied at an appropriate resolution for print publication.
Colour: 300 dpi minimum; please convert all colour files into CMYK mode.
Greyscale: 600 dpi minimum for black-and-white photographs.
Line art: 1,200 dpi minimum for graphs and illustrations.
Please do not scan laser printouts of figures and send them to us as digital files. The dot pattern on a laser print often creates a moire pattern when scanned.
6. Figure captions.
Each caption should start with a brief introductory sentence to describe the figure as a whole, before going on to describe each panel of the figure (labelled a, b, c, etc.) in more detail, including any symbols that are used. The caption for each figure should not exceed 150 words.
7. References.
** As a guideline, a Consensus Statement allows up to ~ 100 references.
** Please check that your formatting is correct.
Please note that Nature Photonics adopts the standard Nature referencing style, i.e. - All authors should be included in reference lists unless there are more than five, in which case only the first author should be given, followed by 'et al.'. Authors should be listed last name first, followed by a comma and initials of given names. There should be no spaces between initials. Article titles should be in Roman text and book titles in italics; the first word of the title is capitalized, the title written exactly as it appears in the work cited, ending with a full stop. Journal names are italicized and abbreviated (with full stops) according to common usage; please refer to Index Medicus for details. Volume numbers should appear in bold. Please correct the format of your references as necessary.
References are numbered sequentially as they appear in the text, tables and figure legends.
We only allow one publication is given for each reference number.
Only papers that have been published or accepted by a named publication should appear in the numbered list; preprints of accepted papers in the reference list should be submitted with the manuscript.
Meeting abstracts and submitted manuscripts should be mentioned in the text with a list of authors (or initials if any of the authors are co-authors of the present contribution).
Authors should avoid excessive use of "unpublished results".
Published conference abstracts and URLs for web sites should be cited parenthetically in the text, not in the reference list.
Grant details and acknowledgements are not permitted as numbered references.
Footnotes are not used.
8. Acknowledgements.
These should appear after the references at the end of the manuscript.
Please keep them brief; professional titles and affiliations are unnecessary.
Grant numbers may be included.
9. Materials & Correspondence.
Please include a statement naming the author to whom correspondence and requests for materials should be addressed.
10. Manuscript file format.
*** When uploading the final version of your manuscript please be sure to include a MS Word .doc format of the main text (our production department handling Reviews/Perspectives/Consensus Statement manuscripts can not process LaTeX, .pdf etc).
We will not send your revised paper for further review if, in the editors' judgement, the referees' comments on the present version have been fully addressed. If the revised paper is in Nature Photonics format, in accessible style and of appropriate length, we shall accept it for publication immediately.
11. Competing Interests
In the interests of transparency, Nature and the Nature Portfolio journals now require authors of most article types to declare any financial and non-financial competing interest. Therefore, on behalf of all authors, we ask that you take particular care to declare any competing interests when submitting your Comment in the Manuscript Tracking System, under the âDetailed Informationâ tab of âManuscript Informationâ. Please also add a competing interests declaration to your article file (if you do not have any competing interests, please include the statement âThe authors declare no competing interestsâ). The competing interests statement will be published with the final article. For more information please see our Competing Interests policy page
12. ORCID
Nature Photonics is committed to improving transparency in authorship. As part of our efforts in this direction, we are now requesting that all authors identified as âcorresponding authorâ create and link their Open Researcher and Contributor Identifier (ORCID) with their account on the Manuscript Tracking System (MTS) prior to acceptance. ORCID helps the scientific community achieve unambiguous attribution of all scholarly contributions. For more information please visit http://www.springernature.com/orcid
For all corresponding authors listed on the manuscript, please follow the instructions in the link below to link your ORCID to your account on our MTS before submitting the final version of the manuscript. If you do not yet have an ORCID you will be able to create one in minutes.
https://www.springernature.com/gp/researchers/orcid/orcid-for-nature-researâŚ
IMPORTANT: All authors identified as âcorresponding authorâ on the manuscript must follow these instructions. Non-corresponding authors do not have to link their ORCIDs but are encouraged to do so. Please note that it will not be possible to add/modify ORCIDs at proof. Thus, if they wish to have their ORCID added to the paper they must also follow the above procedure prior to acceptance.
To support ORCID's aims, we only allow a single ORCID identifier to be attached to one account. If you have any issues attaching an ORCID identifier to your MTS account, please contact the http://platformsupport.nature.com/"">Platform Support Helpdesk.
13. CONSORTIA AUTHORSHIP
For papers containing one or more consortia, all members of the consortium who contributed to the paper must be listed in the paper (i.e., print/online PDF). If necessary, individual authors can be listed in both the main author list and as a member of a consortium listed at the end of the paper. When submitting your revised manuscript via the online submission system, the consortium name should be entered as an author, together with the contact details of a nominated consortium representative. See https://www.nature.com/authors/policies/authorship.html for our authorship policy and https://www.nature.com/documents/nr-consortia-formatting.pdf for further consortia formatting guidelines, which should be adhered to prior to acceptance.
Before we can proceed with final acceptance of your manuscript, you will need to submit a final version of the revised manuscript text and all publication quality figures (if the figures are from your group), together with a point-by-point response to all of the referees' concerns, as well as our editorial requests. Please use the following link to do this:
LINK I SHOULD DELETE
* This URL links to your confidential homepage and associated information about manuscripts you may have submitted or be reviewing for us. If you wish to forward this e-mail to co-authors, please delete this link to your homepage first.
Nature Photonics has now transitioned to a unified Rights Collection system which will allow our Author Services team to quickly and easily collect the rights and permissions required to publish your work. Once your paper is accepted, you will receive an email in approximately 10 business days providing you with a link to complete the grant of rights.
Please note that you will not receive your proofs until the publishing agreement has been received through our system.
If you have any questions please contact ASJournals(a)springernature.com.
* Suggestions for cover illustrations, which should be provided as high resolution electronic files, are welcome. Please note that such pictures should be selected more for their aesthetic appeal than for their scientific content. As I am sure you will understand, we cannot make any promise as to whether any of your suggestions might be selected for the cover of Nature Photonics.
Carefully following the guidelines outlined above, as well as those listed in the Nature Photonics Guide to Authors (www.nature.com/nphoton/authors/index.html) will eliminate any unnecessary delays in the processing of your manuscript once it is formally accepted.
** We hope to hear from you within three weeks; please let us know if the revision process is likely to take longer.
In recognition of the time and expertise our reviewers provide to Nature Photonicsâs editorial process, we would like to formally acknowledge their contribution to the external peer review of your manuscript entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials". For those reviewers who give their assent, we will be publishing their names alongside the published article. We will not be publishing any of the submitted peer review comments.
And finally, you may be aware that Nature Photonics encourages the posting of submitted manuscripts on the preprint server, www.arxiv.org. We do, however, ask you to respect our policy on the posting of particular versions of the manuscript, summarized as follows:
1. You are welcome to post the original submitted version of the manuscript at any time.
2. The accepted version of the manuscript, following the review process, may only be posted 6 months after the paper is published in Nature Photonics.
3. The published version - copyedited and in Nature Photonics format - may not be posted in the arxiv or on authors' websites.
Best wishes,
Dr Giampaolo Pitruzzello
Senior Editor
Nature Photonics
*****************************************************
Please see our Guide to Preparing Final Artwork here: https://www.nature.com/documents/NRJs-guide-to-preparing-final-artwork.pdf for detailed instructions of how to format your figures.
Reviewersâ Comments:
--------------------
Reviewer #1 (Remarks to the Author):
The authors have thoroughly addressed all my concerns, and I have no additional comments. I fully support the publication of this manuscript without delay.
Reviewer #2 (Remarks to the Author):
The authors addressed my previous comments satisfactorily, and I recommend that the manuscript be accepted for publication in its current form.
*****************************************************
This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS
Confidentiality Statement:
This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com .
Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html
Privacy Policy | Update Profile
8
7
Re: FW: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A
by Czarske, Juergen Feb. 26, 2025
by Czarske, Juergen Feb. 26, 2025
Feb. 26, 2025
Hurray,
Now we should drink a glass of champagne today. I'll drink at least two, as we're also celebrating a promotion today. Really great news
âI have some good news. Your revised Consensus Statement article entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" has now been seen by the original referees #1 and #2, and their comments are included below. In light of their advice, I am delighted to say that we can now in principle offer to publish it,â
âŚ.to Kareem and all colleagues, congratulations and thank you for your commitment towards Impact 32,3
Mit freundlichen GrĂźĂen / Best regards,
Juergen
-------------------------------------------------------
Prof. Dr.-Ing. habil. Prof. h. c. Juergen Czarske
Head of Laboratory of Measurement and Sensor Systems
Director of Institute of Circuits and Systems
Director of Competence Center Biomedical Computational Laser Systems (BIOLAS)
TUD Dresden University of Technology
Fakultät Elektrotechnik und Informationstechnik / Faculty of Electrical and
Computer Engineering
Institut fĂźr Grundlagen der Elektrotechnik und Elektronik / Institute of Circuits and Systems
Professur fĂźr Mess- und Sensorsystemtechnik / Chair of Measurement and
Sensor Systems
Competence Center Biomedical Computational Laser Systems
Co-opted Professor of Physics, Institute of Applied Physics, TU Dresden
Adjunct Professor of Optical Sciences, Wyant College, University of Arizona
01062 Dresden, Germany
Tel.: +49 (351) 463-34803
Fax: +49 (351) 463-37716
E-Mail: juergen.czarske(a)tu-dresden.de
Internet: http://www.lasermetrology.de
https://tu-dresden.de/ing/elektrotechnik/iee/mst
https://tu-dresden.de/ing/elektrotechnik/iee/mst/ressourcen/dateien/professâŚ
Fellow OPTICA/OSA (The Optical Society, Washington, DC, USA)
Fellow SPIE (The International Society for Optics and Photonics, Bellingham, WA, USA)
Fellow EOS (European Optical Society, Joensuu, Finland)
Fellow IET (Institution of Engineering and Technology, London, UK)
Fellow IoP (Institute of Physics, London, UK)
Elected Vice President of ICO (International Commission for Optics, Palaiseau/Paris, France & Miami, USA)
Symposium â20 years of Chair MST/Czarske Lab: From Biomedical to Quantum Systems (IYQ)â, 04 April 2025
SF:
Conference Presentation
Multicore fiber modified via ablation and thermal treatment for lensless endoscopic imaging
25 January 2025 ⢠2:25 PM - 2:40 PM PST | Moscone South, Room 212 (Level 2)
<image001.png>
Conference Presentation
Endomicroscopy through a multicore fiber using a static multispectral hologram for wavefront shaping
26 January 2025 ⢠2:00 PM - 2:20 PM PST | Moscone South, Room 308 (Level 3)
<image001.png>
Conference Presentation
Fiber Endoscopy Using Synthetic Wavelengths for 3D tissue imaging
26 January 2025 ⢠10:00 AM - 10:20 AM PST | Moscone South, Room 306 (Level 3)
<image001.png>
Conference Presentation
Digital holography and physics-informed neural networks for mode decomposition of multimode fibers towards classical and quantum communication
29 January 2025 ⢠3:00 PM - 3:30 PM PST | Moscone West, Room 2006 (Level 2)
<image001.png>
Conference Presentation
End-to-end brain cancer diagnosis using high-resolution fiber endoscopy with a learning-based digital twin
26 January 2025 ⢠11:00 AM - 11:20 AM PST | Moscone South, Room 203 (Level 2)
<image001.png>
Conference Presentation
Computational 3D fiber endoscopy with end-to-end optimization by physics-informed deep learning
26 January 2025 ⢠9:40 AM - 10:00 AM PST | Moscone South, Room 306 (Level 3)
<image001.png>
Conference Presentation
Excitation wavefront tracking and control of in vitro human induced cardiomyocytes using a digital holographic stimulation system
25 January 2025 ⢠5:00 PM - 5:20 PM PST | Moscone South, Room 155 (Upper Mezz)
Von: Kareem Elsayad <kareem.elsayad(a)meduniwien.ac.at>
Datum: Mittwoch, 26. Februar 2025 um 04:24
An: "consensus(a)biobrillouin.org" <consensus(a)biobrillouin.org>
Betreff: [Consensus Statement] FW: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A
Hi All,
Just quick update I got & wanted to share đ
Should be able to deal with this without your help -- only formatting stuff (but will contact you individually if/as needed).
Will keep you posted, and I guess you will get some form of confirmation when uploaded again.
Thanks again for being part of this & see you latest (hopefully) in Boston!
All the best,
Kareem
From: <giampaolo.pitruzzello(a)nature.com>
Reply to: <giampaolo.pitruzzello(a)nature.com>
Date: Wednesday, 26. February 2025 at 03:30
To: <kareem.elsayad(a)meduniwien.ac.at>
Subject: [EXTERN] Decision on Nature Photonics manuscript NPHOT-2024-04-00624A
25th February 2025
* Please ensure you delete the link to your author homepage in this e-mail if you wish to forward it to your co-authors.
Dear Kareem,
I have some good news. Your revised Consensus Statement article entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" has now been seen by the original referees #1 and #2, and their comments are included below. In light of their advice, I am delighted to say that we can now in principle offer to publish it, provided that you revise the paper to format it in accordance with our needs described below.
Our format requirements are explained in full at www.nature.com/nphoton/authors/index.html.
1. Title.
To avoid unwieldy titles, we ask that you use no more than 15 words, and no punctuation.
I believe that the current title is sufficiently clear and concise and that no further changes are needed.
2. Headings.
I think that the current headings are suitable and suggest no changes are made.
3. Abstract.
The abstract should serve as a general introduction to the topic, underlining the importance and relevance of a particular area, and as a brief guide to the coverage of the Consensus Statement article. Because we hope that scientists in a wide range of research areas will be interested in our articles, the abstract should be as accessible as possible, explaining essential but specialised terms concisely. We encourage you to show your abstract to colleagues in other fields to uncover any problematic concepts.
This paragraph must contain no more than 120 words and should not include references.
I suggest the version below which has been edited for reasons of length and clarity:
Brillouin Light Scattering (BLS) spectroscopy is a non-invasive, non-contact, label-free optical technique that can provide information on the mechanical properties of a material on the sub-micron scale. Over the last decade, BLS has seen increased applications in the life sciences, driven by the observed significance of mechanical properties in biological processes, the realization of more sensitive BLS spectrometers and the extension of BLS to an imaging modality. As with other spectroscopic techniques, BLS measurements not only detect signals characteristic of the investigated sample, but also of the experimental apparatus, and can be significantly affected by measurement conditions. Here, we report a consensus between researchers in the field. We aim to improve the comparability of BLS studies by providing reporting recommendations for the measured parameters and detailing common artifacts. Given that most BLS studies of biological matter are still at proof-of-concept stages and use different, often self-built, spectrometers, a consensus statement is particularly timely to ensure unified advancement.
4. Main text.
Please take care to ensure that the length does not exceed 6000 words
To ensure that a Consensus Statement article is likely to be accessible to as many readers as possible, it may be useful to ask a colleague from another discipline to read the manuscript before resubmitting it.
** Please ensure that all acronyms and symbols in equations are defined when first introduced.
** Please use UK English throughout.
** Please use a plain black font with no high highlighting or underlining.
** Please remove all figures from the main text and supply them as separate files.
5. Figures.
A Consensus Statement typically contains 4-6 display items (figures, tables and boxes) and these should be supplied separately from the main text.
*** Please ensure that all figures have scale bars as appropriate.
*** Please ensure that all axes of graphs are labelled clearly and supplied with units.
If your figures contain several parts, the parts should be labelled lower case a, b, and so on, and form a neat rectangle when assembled. For detailed instructions, please see our Guide for Authors at https://www.nature.com/documents/NRJs-guide-to-preparing-final-artwork.pdf
If you have reproduced or adapted figure from other venues, please provide us full details of the figures so that we can approach the relevant authors for high-resolution files and the relevant publishers for figure permissions. The form can be found here:
http://www.nature.com/documents/thirdpartyrights-table.doc
If the figures come from your group, please provide us their high-resolution files. Below are some of the guidelines. For more details, please refer to the digital figure guidelines at the end of this email.
Figure files must be supplied at an appropriate resolution for print publication.
Colour: 300 dpi minimum; please convert all colour files into CMYK mode.
Greyscale: 600 dpi minimum for black-and-white photographs.
Line art: 1,200 dpi minimum for graphs and illustrations.
Please do not scan laser printouts of figures and send them to us as digital files. The dot pattern on a laser print often creates a moire pattern when scanned.
6. Figure captions.
Each caption should start with a brief introductory sentence to describe the figure as a whole, before going on to describe each panel of the figure (labelled a, b, c, etc.) in more detail, including any symbols that are used. The caption for each figure should not exceed 150 words.
7. References.
** As a guideline, a Consensus Statement allows up to ~ 100 references.
** Please check that your formatting is correct.
Please note that Nature Photonics adopts the standard Nature referencing style, i.e. - All authors should be included in reference lists unless there are more than five, in which case only the first author should be given, followed by 'et al.'. Authors should be listed last name first, followed by a comma and initials of given names. There should be no spaces between initials. Article titles should be in Roman text and book titles in italics; the first word of the title is capitalized, the title written exactly as it appears in the work cited, ending with a full stop. Journal names are italicized and abbreviated (with full stops) according to common usage; please refer to Index Medicus for details. Volume numbers should appear in bold. Please correct the format of your references as necessary.
References are numbered sequentially as they appear in the text, tables and figure legends.
We only allow one publication is given for each reference number.
Only papers that have been published or accepted by a named publication should appear in the numbered list; preprints of accepted papers in the reference list should be submitted with the manuscript.
Meeting abstracts and submitted manuscripts should be mentioned in the text with a list of authors (or initials if any of the authors are co-authors of the present contribution).
Authors should avoid excessive use of "unpublished results".
Published conference abstracts and URLs for web sites should be cited parenthetically in the text, not in the reference list.
Grant details and acknowledgements are not permitted as numbered references.
Footnotes are not used.
8. Acknowledgements.
These should appear after the references at the end of the manuscript.
Please keep them brief; professional titles and affiliations are unnecessary.
Grant numbers may be included.
9. Materials & Correspondence.
Please include a statement naming the author to whom correspondence and requests for materials should be addressed.
10. Manuscript file format.
*** When uploading the final version of your manuscript please be sure to include a MS Word .doc format of the main text (our production department handling Reviews/Perspectives/Consensus Statement manuscripts can not process LaTeX, .pdf etc).
We will not send your revised paper for further review if, in the editors' judgement, the referees' comments on the present version have been fully addressed. If the revised paper is in Nature Photonics format, in accessible style and of appropriate length, we shall accept it for publication immediately.
11. Competing Interests
In the interests of transparency, Nature and the Nature Portfolio journals now require authors of most article types to declare any financial and non-financial competing interest. Therefore, on behalf of all authors, we ask that you take particular care to declare any competing interests when submitting your Comment in the Manuscript Tracking System, under the âDetailed Informationâ tab of âManuscript Informationâ. Please also add a competing interests declaration to your article file (if you do not have any competing interests, please include the statement âThe authors declare no competing interestsâ). The competing interests statement will be published with the final article. For more information please see our Competing Interests policy page
12. ORCID
Nature Photonics is committed to improving transparency in authorship. As part of our efforts in this direction, we are now requesting that all authors identified as âcorresponding authorâ create and link their Open Researcher and Contributor Identifier (ORCID) with their account on the Manuscript Tracking System (MTS) prior to acceptance. ORCID helps the scientific community achieve unambiguous attribution of all scholarly contributions. For more information please visit http://www.springernature.com/orcid
For all corresponding authors listed on the manuscript, please follow the instructions in the link below to link your ORCID to your account on our MTS before submitting the final version of the manuscript. If you do not yet have an ORCID you will be able to create one in minutes.
https://www.springernature.com/gp/researchers/orcid/orcid-for-nature-researâŚ
IMPORTANT: All authors identified as âcorresponding authorâ on the manuscript must follow these instructions. Non-corresponding authors do not have to link their ORCIDs but are encouraged to do so. Please note that it will not be possible to add/modify ORCIDs at proof. Thus, if they wish to have their ORCID added to the paper they must also follow the above procedure prior to acceptance.
To support ORCID's aims, we only allow a single ORCID identifier to be attached to one account. If you have any issues attaching an ORCID identifier to your MTS account, please contact the http://platformsupport.nature.com/"">Platform Support Helpdesk.
13. CONSORTIA AUTHORSHIP
For papers containing one or more consortia, all members of the consortium who contributed to the paper must be listed in the paper (i.e., print/online PDF). If necessary, individual authors can be listed in both the main author list and as a member of a consortium listed at the end of the paper. When submitting your revised manuscript via the online submission system, the consortium name should be entered as an author, together with the contact details of a nominated consortium representative. See https://www.nature.com/authors/policies/authorship.html for our authorship policy and https://www.nature.com/documents/nr-consortia-formatting.pdf for further consortia formatting guidelines, which should be adhered to prior to acceptance.
Before we can proceed with final acceptance of your manuscript, you will need to submit a final version of the revised manuscript text and all publication quality figures (if the figures are from your group), together with a point-by-point response to all of the referees' concerns, as well as our editorial requests. Please use the following link to do this:
LINK I SHOULD DELETE
* This URL links to your confidential homepage and associated information about manuscripts you may have submitted or be reviewing for us. If you wish to forward this e-mail to co-authors, please delete this link to your homepage first.
Nature Photonics has now transitioned to a unified Rights Collection system which will allow our Author Services team to quickly and easily collect the rights and permissions required to publish your work. Once your paper is accepted, you will receive an email in approximately 10 business days providing you with a link to complete the grant of rights.
Please note that you will not receive your proofs until the publishing agreement has been received through our system.
If you have any questions please contact ASJournals(a)springernature.com.
* Suggestions for cover illustrations, which should be provided as high resolution electronic files, are welcome. Please note that such pictures should be selected more for their aesthetic appeal than for their scientific content. As I am sure you will understand, we cannot make any promise as to whether any of your suggestions might be selected for the cover of Nature Photonics.
Carefully following the guidelines outlined above, as well as those listed in the Nature Photonics Guide to Authors (www.nature.com/nphoton/authors/index.html) will eliminate any unnecessary delays in the processing of your manuscript once it is formally accepted.
** We hope to hear from you within three weeks; please let us know if the revision process is likely to take longer.
In recognition of the time and expertise our reviewers provide to Nature Photonicsâs editorial process, we would like to formally acknowledge their contribution to the external peer review of your manuscript entitled "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials". For those reviewers who give their assent, we will be publishing their names alongside the published article. We will not be publishing any of the submitted peer review comments.
And finally, you may be aware that Nature Photonics encourages the posting of submitted manuscripts on the preprint server, www.arxiv.org. We do, however, ask you to respect our policy on the posting of particular versions of the manuscript, summarized as follows:
1. You are welcome to post the original submitted version of the manuscript at any time.
2. The accepted version of the manuscript, following the review process, may only be posted 6 months after the paper is published in Nature Photonics.
3. The published version - copyedited and in Nature Photonics format - may not be posted in the arxiv or on authors' websites.
Best wishes,
Dr Giampaolo Pitruzzello
Senior Editor
Nature Photonics
*****************************************************
Please see our Guide to Preparing Final Artwork here: https://www.nature.com/documents/NRJs-guide-to-preparing-final-artwork.pdf for detailed instructions of how to format your figures.
Reviewersâ Comments:
--------------------
Reviewer #1 (Remarks to the Author):
The authors have thoroughly addressed all my concerns, and I have no additional comments. I fully support the publication of this manuscript without delay.
Reviewer #2 (Remarks to the Author):
The authors addressed my previous comments satisfactorily, and I recommend that the manuscript be accepted for publication in its current form.
*****************************************************
This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS
Confidentiality Statement:
This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com .
Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html
Privacy Policy | Update Profile
2
1